| Description | hCA/VEGFR-2-IN-1 (compound 13a) is a potent dual inhibitor targeting both Carbonic Anhydrase (CA) IX/XII and Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2). It exhibits Ki values of 4.7 nM for hCA XII and 8.3 nM for hCA IX, alongside an IC50 of 26.3 nM for VEGFR-2. This compound demonstrates anticancer activity [1]. |
| molecular weight | 452.46 |
| Molecular formula | C21H17FN6O3S |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |